Delivery Order SPE2DB20D9127-SPE2DB23FPQH7
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,006.95, is for the delivery of the drug Lenvima 10 mg daily dose 30s. This order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which allows the DLA to issue delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,013.90 contract is for the delivery of LENVIMA 10 MG DAILY DOSE 30S, a specialized pharmaceutical product. The contract has an ultimate completion date of August 12, 2024 and is not associated with any set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999...
- This contract award is a firm fixed-price delivery order from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,006.95, is for the supply of Lenvima 4 mg capsules. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued up to $499,999,999 and valid through November 2026. This IDC enables the DLA to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $21,324.32, is for the delivery of 4,563,981,912 units of the prescription drug Lenvima (20 mg daily dose, 60 capsules) to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,006.95, is for the delivery of Lenvima 10 mg daily dose 30s, a specialized prescription medication. The contract has an ultimate completion date of December 10, 2024 and was awarded on November 18, 2024. DMS Pharmaceutical Group Inc. holds a larger Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,013.90 contract is for the supply of Lenvima 10 mg daily dose prescription medication. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,662.16, is for the delivery of Lenvima 14 mg daily dose 60s, a specialized pharmaceutical product. The award is not associated with a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,006.95 firm fixed-price delivery order is for the supply of Lenvima 12 mg daily dose 90 tablets. It is issued under a larger DLA Indefinite Delivery Contract (IDC), valued at $499,999,999, that enables the DLA to place delivery orders for a comprehensive range of pharmaceutical products to support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,006.95 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the supply of LENVIMA 20MG DAILY 60S, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which covers a comprehensive range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,662.16 award is for the procurement of LENVIMA 14 MG DAILY DOSE 60S, a specialized pharmaceutical product. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB23FPQH7Delivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,662.16, is for the delivery of Lenvima 10 mg daily dose 30s, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 4/6/23 |